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Abstract: About 300 alkaloid structures isolated from marine ascidians are discussed in 
term of their occurrence, structural type and reported pharmacological activity. Some major 
groups (e.g., the lamellarins and the ecteinascidins) are discussed in detail, highlighting their 
potential as therapeutic agents for the treatment of cancer or viral infections. 
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1. Introduction 
Ascidians belong to the phylum Chordata, which encompasses all vertebrate animals, including 
mammals and, therefore, they represent the most highly evolved group of animals commonly 
investigated by marine natural products chemists. Together with the other classes (Thaliacea, 
Appendicularia, and Sorberacea) included in the subphylum Urochordata (=Tunicata), members of the 
class Ascidiacea are commonly referred to as tunicates, because their body is covered by a saclike case 
or tunic, or as sea squirts, because many species expel streams of water through a siphon when 
disturbed. There are roughly 3,000 living species of tunicates, of which ascidians are the most 
abundant and, thus, the mostly chemically investigated. An interest in ascidians’ chemistry was 
kindled as early as 1847, when a German physiologist discovered the presence in the blood cells of 
these invertebrates of large amounts of vanadium and sulfuric acid, along with an uncharacterized 
nitrogenous metabolite. The conquest to understand the role of vanadium in ascidians’ blood has led to 
a huge amount of chemical and biological studies and led to the isolation very unstable hydroquinoid 
compounds, called tunichromes [1,2], whose biological function as well as functional role in the 
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vanadium complexation remains still unclear [3,4]. Then, attention has focused on ascidians because of 
their biologically active metabolites and the chemistry of ascidians has become one of the most active 
fields of marine natural products; it has been amply demonstrated that these sea creatures are prolific 
producers of unusual structures with significant bioactivities [5,6]. 
Ascidians’ chemistry is dominated by the presence of nitrogenous metabolites which could be 
basically divided into two structural type-based groups, peptides and polycyclic aromatic alkaloids. 
This review describes the chemistry of ascidians’ alkaloids; its overall goal is to display the huge 
chemical diversity in this group of marine secondary metabolites. Ascidians’ alkaloids class indeed 
includes a large variety of structures, ranging from complex pyridoacridines and tyrosine-derived 
alkaloids to simple protoalkaloids. About 300 alkaloid structures isolated from marine ascidians will 
be discussed in term of their occurrence, structural type and reported pharmacological activity. They 
will be presented in an order based on their general structural type or on a plausible biosynthetic origin 
(amino acid origin). Some major groups (e.g., the lamellarins and the ecteinascidins) will be discussed in 
detail, highlighting their potential as therapeutic agents for the treatment of cancer or viral infections. 
2. Pyridoacridine Alkaloids 
Pyridoacridine alkaloids isolated from ascidians are typically tetra- or penta-cyclic aromatic 
alkaloids based on the pyrido[k,l]acridine skeleton, usually possessing a functionalized alkylamine side 
chain. Many of these compounds have generated interest both as challenging problems for structure 
elucidation and synthesis as well as for their bioactivities. In general, pyridoacridines are cytotoxic and 
some of them possess potent anti-viral, anti-fungal, anti-bacterial, anti-tumor and anti-parasitic activity [7]. 
For the majority of this class, cytotoxicity has been shown to be due to DNA-binding properties, 
topoisomerase (TOPO) inhibition or the production of reactive oxygen species (ROS) [7]. In fact, the 
main structural feature of these alkaloids is the core of a planar iminoquinone moiety which can 
intercalate into DNA and cleave the DNA double helix or inhibit the action of TOPO II. Thus, there 
has been considerable interest on the potential of these compounds as antitumor agents [8,9]; the great 
chemical diversity in this family of alkaloids provided a large set of tools to manipulate the TOPO II 
activity, either stimulating cleavage of DNA through stabilization of covalent TOPO II-DNA 
complexes or promoting the catenation of DNA [10]. During the past 25 years, both natural pyridoacridines 
and their analogues have constituted excellent targets for synthetic works [9], confirming that this 
family of alkaloids as a whole is of interest as a source of new lead structures for drug development. 
The known tetracyclic pyridoacridine alkaloids from marine sources are dominated by those 
isolated from ascidians. They show an oxygen function at C-8, which can be a carbonyl group, a 
hydroxyl, or an ether moiety. Pantherinine (1), isolated from Aplidium pantherinum [11] and cystodytins 
A–K (2–12), from an Okinawan Cystodytes dellechiajei [12-15], belong to the iminoquinone series. 
Cystodytins were shown to possess, in addition to a potent cytotoxic activity, powerful Ca2+-releasing 
activity in the sarcoplasmatic reticulum [12]. Diplamines A (13), from a Diplosoma sp. [16], and B (14), 
from Lissoclinum cf. badium [17], possess a thiomethyl functionality on the aromatic nucleus at C-9, 
which seems critical for cytotoxicity; furthermore, movement of this function from C-9 to C-5 in 
isodiplamine (15), from L. notti [15], reduces cytotoxicity. Strictly related to diplamines are lissoclins 
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A and B (16 and 17), from an Australian Lissoclinum sp. [18]; unfortunately, the cytotoxic properties 
of these two alkaloids have not been investigated. 
Nor-segoline (18), from a purple tunicate from the Red Sea, Eudistoma sp. [19,20], varamines 19 
and 20, from a Fijian collection of L. vareau [21], and styelsamines 21–24, from an Indonesian 
collection of Eusynstela latericius [22], possess the 11H-pyrido[4,3,2-m,n]acridine nucleus; nor-segoline 
exhibited potent antileukemic properties [23] and varamines were strongly cytotoxic (Figure 1). 
Figure 1. Tetracyclic pyridoacridine alkaloids from ascidians. 
 
Pentacyclic pyridoacridines show an additional heterocyclic ring, generally fused at C9,10 or at 
C8,9 of the acridine ring C. For example, ascididemin (25), from a Didemnum sp. [24], and meridine 
(26) [25], from Amphicarpa meridiana, highly cytotoxic alkaloids, both contain a further pyridine 
moiety. The shermilamines 27–32, isolated from a Trididemnum sp., are thiazinone-containing 
pentacyclic alkaloids differing in their C-12 side chains [26-29]. A series of thiazole-containing 
compounds, kuanoniamines A–F (33–39), have been isolated from both an unidentified Micronesian 
ascidian and the Lamellariidae mollusk Chelynotus semperi, believed to be a predator of the  
ascidian [30,31]. Kuanoniamines B–F (34–39) differ in their acylated phenethylamine side chains, 
while structure of kuanoniamine A possesses the same tetracyclic iminoquinone-containing 
pyridoacridine ring system found in ascididemin (25). Lissoclinidines 40, 41, isolated from ascidians 
of Lissoclinum genus [15,17], feature a benzoxathiole moiety, while both sebastianines 42 and 43, 
from a Brazilian collection of Cystodites dellechiaiei [32], and arnoamines 44 and 45, from a 
Cystodites sp. [33], contain a pyrrole ring (Figure 2). 
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Figure 2. Pentacyclic pyridoacridine alkaloids from ascidians. 
 
Segolines (46, segoline A), possessing a benzo-1,6-diazaphenantroline ring system, eilatin (47), 
having an unusual symmetrical heptacyclic structure, and eudistones (48, eudistone A) are more 
complex pyridoacridines (Figure 3). All these alkaloids have been isolated from Eudistoma  
ascidians [18,19,34-36] and have been shown to be potent regulators of cellular growth and 
differentiation and affect cAMP-mediated processes [37]. Eilatin (47) can form complexes with metal 
ions and these complexes represent a new family of compounds with unusual nucleic acid binding 
specificity [38] (Figure 3). 
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Figure 3. Structures of segoline A (46), eilatin (47), and eudistone A (48). 
 
3. Carboline-Based Alkaloids 
Polysubstituted -carbolines, as well as dihydro-, and tetrahydro--carbolines form a large group of 
tryptophan-derived ascidian metabolites. The majority of these alkaloids have been isolated from 
tunicates belonging to the genus Eudistoma [39-52], but other sources are the genera Ritterella [53,54], 
Pseudodistoma [55-57], Didemnum [58-62], Synoicum [63], and Lissoclinum [64,18]. Almost all the 
reported compounds are hydroxylated and/or brominated at C5, C6, C7, and C8; apart from few 
members of the group, which are unsubstituted at C1, they show different substituents at this position, such 
as pyrrole, pyrroline, or indole rings, as well as oxygenated, aminatated, or thiomethylated alkyl residues. 
Actually, all of the -carboline metabolites isolated thus far are related biosynthetically; the 
production of these metabolites is generally believed to involve the coupling of tryptophan with a 
second amino acid, whose nature clearly affects C1 substitution. For example, eudistomins A (54), M 
(55), G (50), and P (52) may be considered to be derived from tryptophan and glutamine [39], while 
the 2-fenylacetyl--carbolines, eudistomines R (56) and T (57), are, in addition to tryptophan, made up 
of phenylalanine or phenylpyruvic acid. Similarly, the unusual aminoacids, p-methylphenyl-L-alanine 
and S-methyl-D-cysteine have been supposed to be involved in the production of eudistomidins B (83) 
and C (64) [46], respectively. A proline-derived precursor is evident in eudistomins G, I, P (50–52), A 
(54), and M (55), eudistomidin A (63), and woodinine (85). In vivo studies with E. olivaceum 
confirmed that tryptophan and proline are the primary precursors of eudistomin I (51) [65]. Some of 
the most intriguing members of these alkaloids are those bearing an oxathiazepine ring (eudistomins C, 
E, F, K, and L, 91–95) which apparently originate from condensation of tryptophan with cysteine [44]. 
Eudistalbins A (65) and B (66) likely derive from leucine. 
Examples of simple -carboline alkaloids are the eudistomins 49–62 [39-43], eudistomidins A (63) 
and C (64) [45,46], and eudistalbins 65 and 66 [49]. Eudistomidin A is the first calmodulin antagonist 
from marine origin (Figure 4) [45]. 
Pseudodistamine (67) [57] as well as 2-methyleudistomins D (68) and J (69) [50] are rare examples 
of N-methyl -carbolinium derivatives described from marine sources, while eudistomidins E (70) and 
F (71) are structurally unique, with a tetrahydropyrimidine ring fused to the -carboline skeleton 
(Figure 5) [47]. 
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Figure 5. N-methyl -carbolinium (67–69) and tetrahydropyrimidine ring containing  
(70 and 71) -carboline derivatives. 
 
 
 
 
 
 
 
Eudistomidin D (72) as well as didemnolines A–D 73–76 differ from the other ascidian -carboline 
metabolites in that they are substituted at the N9 position of the -carboline ring, rather than at the C1 
position [46,58]. Tiruchanduramide (77) is a -carboline guanidine alkaloid and it is the sole  
3-substituted -carboline isolated to date from ascidians (Figure 6) [63]. Shishijimicins (shishijimicin 
A, 78) are perhaps the most complex -carbolines from ascidians; they belong to the enediyne class of 
antibiotics, which are also potent antitumor agents (Figure 7) [59]. 
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Figure 6. N9-(72–76) and C3-substituted (77) -carbolines. 
 
 
 
 
 
 
 
 
 
Figure 7. Structures of shishijimicin A (78). 
 
 
 
 
 
Both symmetrical (79) and non-symmetrical -carboline dimers (80–82) have been reported from 
Didemnum sp. and their structures were confirmed by synthesis [60,61]. Compound 79 was known as a 
synthetic compound derived from photochemical dimerization of -carboline (norharmane) but it is the 
first example of naturally occurring -carboline dimer (Figure 8). 
Numerous tetrahydro--carbolines with various substituents at C1 have been reported from ascidians; 
they include eudistomidins B (83) and G (84) [46,48], woodinine (85) [51], lissoclin C (86) [18], and 
compound 87, the 1-carboxyl analogue of trypargine, a tetrahydro--carboline previously isolated from 
the skin of the African frog Kassina senegalensi (Figure 9) [52]. 
Arborescidines B–D (88–90) [56], eudistomins C, E, F, K, L (91–95) [44], K-sulfoxide (97) [53], 
and debromoeudistomin K (96) [54] contain a 7-membered additional ring attached to the tetrahydro  
-carboline moiety which, in the case of the eudistomins, is an oxathiazepine ring (Figure 10). 
Bengacarboline (98) is a tetrahydro--carboline with two indole units attached to C1 of the carboline 
nucleus (Figure 11); it resulted cytotoxic toward a 26 cell line human tumor panel in vitro and 
inhibited the catalytic activity of TOPO II [62]. 
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Figure 8. Symmetrical (79) and non-symmetrical (80–82) -carboline dimers. 
 
Figure 9. Tetrahydro--carbolines. 
 
 
 
 
 
 
 
Figure 10. 7-Membered additional ring containing tetrahydro -carbolines. 
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Figure 11. Structure of bengacarboline (98). 
 
The -carboline alkaloids display a variety of biological activities, including a broad spectrum of 
antibiotic activity, cytotoxicity, calmodulin antagonistic properties. However, the most notable 
pharmacological feature is the strong antiviral properties displayed by some members of the  
family [66,67]. The tetrahydro--carbolines generally exhibited higher levels of biological activity than 
their fully aromatic relatives; the oxathiazepino-eudistomins 88–94, for example, exhibit the highest 
level of antiviral activity and were also endowed with antimicrobial activity. Eudistomin K (91) is 
significantly active against Herpes simplex Type I (HSV-1) and Polio virus, while the sulfoxide (94) 
and debromo (90) derivatives are active against both virus but less potent. Enhancement of antiviral 
activity correlates to bromination at C7 (Figure 12). 
Figure 12. Dihydro--carbolines (99, 100) and -carbolines (101–103). 
 
There are only few examples of reported dihydro--carbolines from ascidians. The first was 
isoeudistomin U (99) which was initially reported to be a 4-substituted dihydro--carboline  
derivative [64], but whose structure was revised to 3,4-dihydroeudistomin U after total synthesis [68]; 
the bioactivity of isoeudistomin U was reported to be similar to that of the related eudistomin U (59). 
A 1,2-dehydro analogue of trypargine, named trypargimine (100), has been reported from a previously 
undescribed Eudistoma sp. [52]. Also -carbolines are not common ascidians’ metabolites. The 
grossularines (101–103) from Dendrodoa grossularia are the sole representatives of this structural 
class and are the first -carbolines to be isolated from a natural source (Figure 12). The initial structure 
reported for grossularine (=grossularine-1) [69] was incorrect and it was revised when data for both 
grossularine-1 (101) and -2 (103) were reported [70]. Both grossularines are cytotoxic and cause 
accumulation of cells in the G1-phase; grossularine-2 appears to act on DNA as a mono-intercalating 
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agent. N,N-didesmethylgrossularine-1 (102) has been reported from Polycarpa aurata but no activity 
data were presented [71]. 
4. Indole-Based Alkaloids 
The structures of indole based alkaloids isolated from ascidians span a wide range of complexity, 
spreading from the simple 6-bromoindole-3-carbaldehyde, isolated from Pyura sacciformis [72] and 
previously found in a marine pseudomonad [73], to the complex indolocarbazoles of the staurosporine 
type 104–112 isolated from ascidians belonging to the family Polycitoridae (Figure 13) [74-79]. 
Staurosporine and its derivatives have been isolated from various actinomycete strains as well as from 
some marine organisms, including ascidians [80]. These alkaloids were shown to be strong inhibitors 
of several kinases, in particular protein kinase C (PKC); other activities include inhibition of platelet 
aggregation and smooth muscle contraction, induction of cell cycle arrest and apoptosis, and the 
reversal of multidrug resistance in some cancer cell lines. The potential of these derivatives as 
anticancer agents is supported by the example of 7-hydroxystaurosporine which is in clinical phase I 
trials at the NCI [77]. 11-Hydroxystaurosporine (105), from Eudistoma sp., is a PKC inhibitor about 
30% more potent than staurosporine [74] whereas 3-hydroxystaurosporine (104), from E. toealensis, is 
one of the most active staurosporine-type inhibitors of cell proliferation described so far [77]. 
Derivatives 111 and 112, from Cystodites solitus, displayed cytotoxic activity in the submicromolar 
range against three human tumour cell lines [79]. 
Figure 13. Staurosporine derivatives 104–112. 
 
 
 
 
 
 
 
A number of 3-substituted indoles have been isolated from ascidians. Examples are 6-bromotryptamine 
(113) and its derivatives 114–116, isolated from Didemnum candidum [81], conicamin (117), from 
Aplidium conicum, with histamine-antagonistic activity [82], citorellamine (118), from Polycitorella 
mariae, the first indole disulfide dihydrochloride from a marine organism [83,84], and the indolyl-3-
glyoxylic acid derivatives polyandrocarpamides A–C (119–121) [85]. Dendrodoa grossularia was the 
source of several indole alkaloids with different heterocyclic moieties linked at the 3-position 
(compounds 122–125) [86-89]. Among them, alboinon (125) contained an oxadiazinone system, found 
in nature for the first time (Figure 14) [88]. 
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Figure 14. 3-Substituted indoles. 
  
Meridianins A–G (126–132), from Aplidium meridianum [90,91], are brominated and/or 
hydroxylated 3-(2-aminopyrimidine)-indoles differing in the bromine and /or hydroxyl substitution 
(Figure 15). They constitute a new family of protein kinase inhibitors, inhibiting various protein 
kinases such as cyclin-dependent kinases, glycogen synthase kinase-3, cyclic nucleotide-dependent 
kinases and casein kinase 1; they also prevent proliferation and induce apoptosis probably due to their 
ability to enter cells and to interfere with the activity of kinases important for cell division and death 
[92]. Structurally related to meridianins are aplicyanins A–F (133–138), from A. cyaneum, containing a  
6-tetrahydropyrimidine substituent at C-3; these alkaloids can be considered reduced forms of the 
relevant meridianins and, thus, their biogenetic precursors (Figure 15) [93]. 
Figure 15. 3-(2-Aminopyrimidine)-indoles (meridianins A–G, 126–132) and their reduced 
forms (aplicyanins A-F, 133–138). 
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Kottamides A–D (139–142), from Pycnoclavella kottae [94], are imidazol-4-one containing 
alkaloids; their biogenesis could involve stereospecific imidazolone ring formation from modified  
Trp-Val-Ile and Trp-Ile-Ala tripeptide precursors (Figure 16) [96]. Kottamide E (143) represent the 
first report of a natural product bearing a 4-amino-1,2-dithiolane-4-carboxylic acid residue [95]. 
Wakayin (144), from Clavelina sp., contains an uncommon pyrroloiminoquinone moiety; it is one of 
the first camptothecin (CPT)-like TOPO I inhibitors isolated from a marine organism, the indole ring 
linked to the bispyrroleiminoquinone core playing a significant role in this activity (Figure 16) [96]. 
Figure 16. Structures of kottamides A–E (139–143) and wakayin (144). 
 
Four predator-deterrent alkaloids possessing a novel indole-maleimide-imidazole carbon skeleton, 
didemnimides A–D (145–148), were isolated from a Caribbean collection of Didemnum conchyliatum [97]. 
They were the first examples of a new alkaloid structural class and add to a relatively small group of 
naturally occurring maleimides. Successively, didemnimide E (149) was isolated from Didemnum 
granulatum collected in Brazil together with a less polar and deep purple cyclized didemnimide 
alkaloid, isogranulatimide (150) [98]. Almost at the same time, Fenical’s group independently obtained 
this compound from D. conchyliatum [99]. Compound 150 is the cyclization product of didemnimide 
A (145) formed via a C-2 indole condensation with the imidazole nitrogen and represented the first 
alkaloid to be isolated with this cyclized indole-maleimide-imidazole structure. Isogranulatimide (150) 
and its isomer granulatimide (151) could be biomimetically synthesized involving the photocyclization 
of 145. Subsequently, 151 and its 6-bromo derivative 152 were obtained as naturally occurring 
compounds from a new collection of Brazilian D. granulatum [100]. Isogranulatimide (150) was 
reported as the first non-cytotoxic, specific G2 cell cycle checkpoint inhibitor, and the mechanism of 
this antitumor action was elucidated at molecular level (Figure 17) [98,101]. 
Apart from the above mentioned staurosporine derivatives 104–112, other examples of bisindole 
alkaloids are rhopaladins 153–156, from Rhopalaea sp., possessing an imidazolinone moiety [102], 
and iheyamines A (157) and B (158), from Polycitorella sp., with a new heteroaromatic skeleton 
composed of an azocine unit fused onto a bisindole system (Figure 18) [103]. The 12H-pyrido[1,2-
a:3,4-b0]diindole ring system forms the framework of the red pigment fascaplysin (159), which was 
isolated in 1988 from the sponge Fascaplysinopsis Bergquist sp. and successively found in other 
Thorectidae sponges; this compound, together with its 3-bromoderivative (160), has been found in 
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some Didemnum collections [62,104,105]. Fascaplysin and its derivatives exhibit a broad range of 
bioactivities including antibacterial, antifungal, antiviral, HIV-1-RT, p56 tyrosine kinase, antimalarial, 
citotoxicity against numerous cancer cell lines, specific inhibition of Cdk 4 and DNA intercalation, 
demonstrating a huge potential for therapeutic assays [106]. 
Figure 17. Indole-maleimide-imidazole alkaloids. 
 
Figure 18. Bisindole alkaloids. 
 
5. Tyrosine- and Phenylalanine-Derived Alkaloids 
Tyrosine is the precursor of a wide number of alkaloids whose structures are characterized by 
possessing the Ar–C2–N subunit derived from Tyr, commonly via dopamine; often, additional Ar–C1 
and Ar–C2 moieties are present, derived from a partial degradation of the amino acids Phe or Tyr. The 
aromatic ring of all these subunits is usually oxygenated at 4-, 3,4-, or 3,4,5-positions. The amino acid 
DOPA [2-amino,3-(3′,4′-dihydroxyphenyl) propionic acid], in particular, appears to play an important 
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role in the ascidians’ metabolism, serving as the apparent precursor not only of peptide products, but 
also of unique alkaloid structures, such as those of lamellarins and ecteinascidins (see below). 
Simple aromatic alkaloids, derived directly or indirectly from phenylalanine, tyrosine, phenylethylamine, 
tyramine, or dopamine, as well as complex highly condensed structures fall in the group of tyrosine- 
and phenylalanine-derived alkaloids. Phenylethylamine (161) itself and its urea derivative 162 have 
been found in a Lissoclinum sp. and in Didemnum ternatanum, respectively [18,107]. Iodinated and/or 
brominated tyramine derivatives, such as compounds 163–172, are often found within ascidians 
metabolites [52,108-112]. The guanidine derivatives tubastrine (173) and its saturated analogue 174 
have been found in a New Zealand collection of Aplidium orthyum [113]; an Australian collection of 
Polycarpa aurata contained the three p-methoxybenzoyl derivatives 175–177 (Figure 19) [114]. 
Figure 19. Iodinated and/or brominated tyramine derivatives. 
 
 
 
 
 
 
 
 
 
 
 
 
Botryllamides (A–J, 178–187) are a series of brominated tyrosine derivatives isolated from several 
Botryllus species (Figure 20) [115-118]; they form a new class of selective inhibitors of ABCG2, a 
human ATP-binding cassette (ABC) transporter gene usually associated with multidrug resistance in 
cancer [117,119]. 
R4
161 R1=R2=R3=H; R4= -CH2CH2NH2
163 R1=I; R2=OMe; R3=I; R4= -CH2CH2NH2
165 R1=I; R2=OMe; R3=I; R4= -CH2CONH2
166 R1=I; R2=OMe; R3=I; R4= -CH2CH2NHCOH
167 R1=I; R2=OMe; R3=I; R4= -CH2CH2NHCOPhe
168 R1=I; R2=OH; R3=H; R4= -CH2CH2NH2
169 R1=I; R2=OH; R3=H; R4= -CH2CH2N(Me)3+
170 R1=Br; R2=OH; R3=H; R4= -CH2CH2NH2
171 R1=Br; R2=OH; R3=Br; R4= -CH2CH2NH2
172 R1=Br; R2=OH; R3=H; R4= -CH2CH2N(Me)3+
173 R1=OH; R2=OH; R3=H; R4= -CH=CHNHCNHNH2
174 R1=OH; R2=OH; R3=H; R4= -CH2CH2NHCNHNH2
175 R1=H; R2=OMe; R3=H; R4= -CONHCNHNH2
176 R1=H; R2=OMe; R3=H; R4= -COCOO(CH2)3CH3
177 R1=H; R2=OMe; R3=H; R4= -COCONHCH3
R1
R2
R3
R1
R2
R3
H
N
H
N R1
R2
R3
O
162 R1=R2=R3=H
164 R1=I; R2=OMe; R3=I
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Figure 20. Structures of botryllamides A–J (178–187). 
 
In some alkaloids, the amino group of what initially was the amino acid residue has ended up as a 
part of a heteroaromatic ring. Examples are the thiazole and imidazole metabolites 188–190, from 
Aplidium pliciferum [120] as well as the polyandrocarpamines A and B (191 and 192), from 
Polyandrocarpa sp. possessing a 2-aminoimidazolone moiety [121]. A condensation between 
phenylalanine and glycine is expected to form the 1,4-diketopiperazine unit present in etzionin (193), 
an unusual antifungal metabolite isolated from an unidentified Red Sea tunicate [122]. Rigidin (194), 
from Eudistoma cf. rigida, was the first pyrrolopyrimidine alkaloid to be isolated from a marine 
source; it exhibited calmodulin antagonistic activity for inhibition of calmodulin-activated brain 
phosphodiesterase [123]. Four rigidin congeners, rigidins B–E (195–198), have been successively 
isolated from Cystodites and Eudistoma species (Figure 21) [124,125]. 
Figure 21. Thiazole (188, 189), imidazole (190), 2-aminoimidazolone (191, 192), 
1,4diketopiperazine (193), and pyrrolopyrimidine (194–198) alkaloids. 
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Botryllazines A and B (199 and 200) have been isolated from Botryllus leachii (Figure 22); the 
structure of botryllazine A is unprecedented since three tyrosine precursors are involved in the 
formation of a pyrazine nucleus. It has been proposed that the biogenetic pathway leading to 
botryllazyne B from two tyrosine units involves amide formation and, subsequently cyclization via 
imine formation [126]. Haouamines A and B (201 and 202), from Aplidium haouarianum [127], 
demonstrates intriguing stereochemical features; in solution, each haouamine exists as an inseparable 
mixture of two interconverting isomers derived by the presence of a highly strained 3-aza-[7]-
paracyclophane moiety in their structures (Figure 22). Even if one Ar–C2–N and three Ar–C2 subunits 
can be readily identified in the structures of haouamines, the oxygenation pattern of all these units, 
hydroxylated at the meta position with respect to the C2 chain, does not allow establishing a 
relationship between these alkaloids and the amino acid tyrosine. Thus, the biosynthesis of these 
alkaloids should imply either an unusual loss of the C4 hydroxyl group of tyrosine along the 
biosynthetic pathway or the involvement of an undescribed natural amino acid precursor exclusively 
meta hydroxylated [127]. 
Figure 22. Structures of botryllazines (199–200) and haouamines (201–202). 
 
The lamellarins form a group of more than 50 highly condensed DOPA- and TOPA-derived pyrrole 
cytotoxic alkaloids which have attracted researchers’ interest due to both their structural originality and 
complex mechanism of action. Lamellarins were first isolated from the prosobranch mollusk 
Lamellaria sp. in 1985 [128]. They were later extracted from and identified in various species of 
Didemnum ascidians [129-134] and sponges [135,136] collected from very diverse areas, which 
suggests a potential microbial link to their biosynthesis [137,138]. 
The lamellarins fall into two structural groups, depending on whether the central pyrrole ring is 
fused (Group I) or unfused (Group II) to adjacent aromatic rings (Figure 23). Group I could be further 
divided into two subgroups, Ia, including compounds with an olefin at C5/C6, and Ib, with compounds 
in which this olefin is saturated. Each group includes derivatives in which phenolic hydroxyl groups 
are substituted by methoxy, sulphate or acetate functions.The lamellarins isolated from ascidians 
possess the hexacyclic skeleton of Group I; selected structures of ascidians’ lamellarins are reported in 
Figure 24. 
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203 R1=R8=OH; R2=R4=R5=R6=R7=OMe; R3=H
204 R1=R5=R8=OH; R2=R4=R6=R7=OMe; R3=H
205 R1=R4=R6=OMe; R2=R5=R7=OH; R3=R8=H
207 R1=OH; R2=R4=R5=R6=R7=R8=OMe; R3=H
208 R1=R7=OH; R2=R4=R5=R6=OMe; R3=H
209 R1=R4=R8=OH; R2=R5=R6=R7=OMe; R3=H
210 R1=R5=R7=OH; R2=R4=R6=OMe; R3=R8=H
213 R1=R6=OMe; R2=R4=R5=R7=OH; R3=R8=H
215 R1=OSO3-; R2=R5=R6=R7=R8=OMe; R4=OH; R3=H
216 R1=OSO3-; R2=R4=R6=OMe; R5=R7=OH; R3=R8=H
217 R1=R4=R6=OMe; R2=R5=OH; R7=OSO3-; R3=R8=H
N
O
O
R1R2R3R4
R5
R6
R7
R8
5
6
N
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O
R1R2R3R4
R5
R6
R7
5
6
206 R1=R2=R3=R4=R5=R6=OH; R7=H
211 R1=R3=R7=OH; R2=R4=R5=R6=OMe;
212 R1=R4=R6=OAc; R2=R3=R5=OMe; R7=H
214 R1=OSO3-; R2=R4=R5=R6=R7=OMe; R3=OH
218 R1=OSO3Na; R2=R3=R5=R6=OMe; R4=OH; R7=H
219 R1=R4=OH; R2=R3=R5=R6=OMe; R7=H
220 R1=R7=OH; R2=R3=R4=R5=R6=OMe
221 R1=OH; R2=R3=R4=R5=R6=R7=OMe
222 R1=OH; R2=R3=R4=R5=R6=OMe; R7=H
223 R1=R3=R5=OAc; R2=R4=R6=R7=OMe
20
8
Lamellarin E
Lamellarin F
Lamellarin G
Lamellarin I
Lamellarin J
Lamellarin K
Lamellarin l
Lamellarin 
Lamellarin 
Lamellarin 
Lamellarin 
Lamellarin H
Lamellarin M
Lamellarin Z
Lamellarin 
Lamellarin N triacetate
Lamellarin G 8-sulfate
Lamellarin B 20-sulfate
Lamellarin C 20-sulfate
Lamellarin L 20-sulfate
Lamellarin  20-sulfate
Figure 23. Core structures of lamellarins. 
 
Figure 24. Structures of lamellarins isolated from ascidians. 
 
 
 
 
 
 
 
A wide range of different biological properties are reported for this family of alkaloids, including 
antibiotic activity, immunomodulation, antioxidant activity [137-139]. A few members of the family 
revealed HIV-1 integrase inhibition activity, although this pharmacological activity has not been so far 
thoroughly explored. The HIV-1 integrase, providing the integration of the proviral DNA into host cell 
chromosomal DNA, constitutes an attractive target because no human cellular homologue of this 
enzyme exists. Lamellarin α 20-sulfate (223) exhibited a potent in vitro inhibition against the HIV-1 
integrase [134]; it is able to act at two different steps of the catalytic cycle, the terminal cleavage and 
the strand transfer. Moreover, this compound inhibits the viral replication in cultured cells at non-toxic 
doses. Its sulphate group plays a critical role because the desulphated analogue lamellarin  (213) is 
inactive. However, the most common and remarkable property of the lamellarins is their capacity to 
inhibit the proliferation of cancer cells. The majority of lamellarins are considerably cytotoxic, with 
IC50 (or LD50) values in the nanomolar to micromolar range, depending on the experimental conditions 
and the nature of the compounds. A noticeable exception is that of the sulphated lamellarins, which are 
not cytotoxic presumably due to reduced cell uptake. Lamellarin D (206) is one of the most cytotoxic 
compounds of the family and, in the series of its derivatives, precise structure-activity relationships 
have been delineated [140]. Analogues with hydroxyl groups at both the C8 and C20 positions are the 
most cytotoxic, whereas the OH at C14 and methoxy groups at C13 and C21 seem to be less important 
to maintain the cytotoxic potential [141]. 
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Lamellarins thus represent an important source of structures to develop anticancer drugs, although 
few aspects of their mechanism of actions are known, in particular their capacities to interfere with 
topoisomerase I and mitochondria, both contributing to their potent cytotoxicity. In particular, TOPO I 
has been found to be the major (but not the unique) target for lamellarin D (206) [142,143]; this key 
discovery has opened the doors to the determination of structure-function relationships and the rational 
design of lamellarin analogues of pharmaceutical interest. For example, the double bond between 
carbons 5 and 6 in the quinoline B-ring is a crucial element for topoisomerase I inhibition [142]. In 
addition, some lamellarins, have been reported to act as nontoxic inhibitors of acquired multidrug 
resistance (MDR) in various cancer cell lines. Lamellarin I (207) is a MDR modulator, inhibiting 
directly P-glycoprotein mediated drug efflux at non-lethal doses [144]. In light of their fascinating 
unique structures and intriguing biological properties, lamellarins still are a particularly important 
subject for synthetic as well as pharmacological studies [137-139]. 
Pyrrole-derived alkaloids related to lamellarin include lukianols (224–225), isolated from an 
unidentified Pacific tunicate [145], polycitones (226–227) and polycitrins (228–229), from Polycitor 
species [146,147], and ningalins (230–233), from Didemnum sp. (Figure 25) [148]. The structures of 
the lukianols A and B contained a pyrrolooxazinone moiety; they appear to arise by the same 
biogenetic pathways leading to lamellarin O and P isolated from the marine sponge Dendrilla cactos [135]. 
Lukianol A (224) inhibited DNA synthesis in L1210 lymphocytic leukemia cell lines with less effect 
on RNA and protein synthesis, demonstrating a therapeutic profile very similar to current clinically 
used anticancer agents [145]. Ningalins A–D (230–233) are condensed aromatic systems with the 
unifying theme that all appear derived from the condensation of two, three, four, and five DOPA 
precursors, respectively. Although a potential role for these alkaloids in metal sequestration has not 
been demonstrated they are structurally related to other metal binding ascidian-derived o-catechols; it 
is thus conceivable that they too participate in the metal chelating phenomena characteristic of this 
class of marine invertebrates [137,145]. 
Tetrahydroisoquinoline alkaloids are uncommon in ascidians, but the sole representatives of this 
class, ecteinascidins, isolated mainly from the Caribbean ascidian Ecteinascidia turbinata, are 
probably the most useful anticancer agents found to date in a marine source. The lead compound, 
Yondelis® (trabectedin, ET-743, 235), is the first representative of a marine natural product to receive 
marketing authorization for the treatment of patients with soft tissue sarcomas (STS) [149]. Apart from 
the biological activity, ET-743 exhibits an extraordinary three-dimensional molecular architecture, 
which has made a fascinating target for the synthetic organic chemists allowing a number of original 
synthetic and semi-synthetic methodologies for the preparation of a wide variety of ecteinascidins to 
be discovered [150]. The first description and structural characterization of six new chemical entities 
called ecteinascidins, ET 729 (234), ET 743 (235), ET 745 (236), ET 759A (237), ET 759B (238), and 
ET 770 (239), was reported by the Rinehart group in 1990 of which ET-743 was the most abundant 
representative [151]. Simultaneously, Wright and coworkers described compounds 234 and 235 [152], 
but the unequivocal assignment of the absolute stereochemistry was achieved only when the X-ray 
crystal structures of the natural N12-oxide of ET-743 (240) and a synthetic O-methyl analogue of  
N12-formyl ET-729 (241) were solved [153]. Successively, a number of additional new members of 
this class of molecules have been isolated, such as compounds 242 and 243 [154], 244–247 [155],  
248 [156], 249–252 [157] (Figure 26). The unique structure of ecteinascidins consists of a monobridged 
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pentacyclic skeleton composed of two fused tetrahydroisoquinoline rings (subunits A and B) linked to 
a 10-membered lactone bridge through a benzylic sulfide linkage. Most ecteinascidins have an 
additional tetrahydroisoquinoline or tetrahydro--carboline ring (subunit C) attached to the rest of the 
structure through a spiro-ring. As for the biogenesis of the ecteinascidins, it has been proposed that  
A-B units could be formed by condensation of two DOPA-derived building blocks, and the 
tetrahydroisoquinoline ring in unit B is closed by condensation with a serine-(or glycine-) derived 
aldehyde as in the case of the related saframycins. S-Adenosylmethionine is the likely source of 
methyl groups at C-6, O-7, C-16, O-17, and N-12 [157]. Initially, ecteinascidins were found to be 
cytotoxic against L1210 leukaemia cells (IC50 value of 0.5 ng/mL) [151] and were later shown to 
possess strong in vivo antitumour effects in various mice models bearing P388 lymphoma, B16 
melanoma, M5076 ovarian sarcoma, lewis and lX-1 human lung carcinoma, and MX-1 human 
mammary carcinoma xenografts [154]. ET-743 (235) was selected for further development; studies on 
its mechanism of action revealed it as the first of a new class of DNA binding agents with a complex, 
transcription-targeted mechanism of action. Trabectedin binds to the minor groove of DNA with 
preference for GC-rich triplets and subsequently forms covalent adducts with the N2-position through 
its carbinolamine moiety [158-160]. ET-743, under the trade name Yondelis, was approved for the 
treatment of refractory soft-tissue sarcomas by the European Commission in July 2007; the currently 
ongoing Phase III trials along with the already existing clinical evidence may provide enough  
data for the Food and Drug Administration for an approval in the US [161]. Based on the preclinical 
results, trabectedin is also being developed for ovarian, prostate, lung, breast and pediatric  
cancers [149,162,163]. 
Figure 25. Structures of alkaloids related to lamellarins. 
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Figure 26. Structures of ecteinascidins. 
 
 
 
 
 
 
 
 
 
 
 
 
6. Lysine-Derived Alkaloids 
Alkaloids based on a 2-amino-3-hydroxyoctadecane moiety, generally referred to as lysine-derived 
metabolites, have been found in several genera of ascidians. Monocyclic examples are the piperidine 
alkaloids, which are among the most abundant metabolites of terrestrial plants, but there are relatively 
few examples isolated from marine organisms. 
Pseudodistomins A (253) and B (254), from Pseudodistoma kanoko, represent the first piperidine 
alkaloids obtained from marine sources [164]. The structure of the side chains of 253 and 254 has been 
revised after the first disclosure of the molecules [165,166], while the stereostructure of the piperidine 
nucleus has been established by synthesis of their tetrahydroacetyl derivatives [167,168]. Other 
members of the group have been successively isolated, from other Pseudodistoma species, including 
pseudodistomin C (255), with the absolute configuration at C-4 and C-5 opposite to those found in 253 
and 254 [169], and pseudodistomins D–F (256–258) (Figure 27) [170]. Pseudodistomins A and B 
exhibited cytotoxic activity with calmodulin antagonistic activity; pseudodistomins B–F were found to 
be active in a cell-based assay for DNA damage induction. Uoamines A (259) and B (260) also are 
monocyclic piperidine alkaloids isolated form Aplidium uouo; in these compounds, the 3-hydroxyl 
group present on the piperidine nucleus is esterified by (E)- or (Z)-3-thiomethylacrylic acid, 
respectively (Figure 27) [171]. 
234 R1=H; R2=OH
235 R1=Me; R2=OH
236 R1=Me; R2=H
237 R1=Me; R2= =O (lactam)
238 R1=Me; R2=OH, S-oxide
239 R1=Me; R2=CN
240 R1=Me; R2= OH, N-oxide
241 R1=CHO; R2= OH
245 R1=Me; R2=CH(CHO)2
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247 R1=H; R2=OH, S-oxide
248 R1=Me; R2=CN, S-oxide
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Figure 27. Structures of piperidine alkaloids pseudodistomins (253–258) and uoamines (259, 260). 
 
Bi-and tricyclic members of the lysine-derived alkaloids group have been most often found in 
Clavelina species and include quinolizidines and indolizidines derivatives. Clavepictines A (261) and 
B (262) and pictamine (263) are homologous quinolizidine alkaloids isolated from Bermudan and 
Venezuelan collections of the tunicate C. picta, respectively [172,173]. With the use of NOE 
experiments, 261 was determined to have a cis ring junction in the quinolizidine moiety, with the 
decadienyl side chain in the equatorial orientation, and the methyl and acetoxy substituents oriented 
trans-diaxial. An X-ray analysis of clavepictine B (262) confirmed the proposed relative 
stereochemistry and conformation. Both clavepictines inhibited the growth of murine leukemia and 
human solid tumor cell lines at concentrations less than 9 g/mL. Pictamine (263) is a bis-nor 
analogue of clavapictine A, bearing two less carbons on the side-chain. C. picta has also been the 
source of a series of indolizidine metabo1ites, piclavines A–C (264–266) (Figure 28) [174]. They 
consist of three series of isomeric compounds, differing in the number of double bonds on the side 
chain. Each group is composed of an inseparable mixture of stereoisomers, which differ at the C2 
chiral center, as well as at each of the double bonds. The piclavines are the first indolizidines isolated 
from a marine source; they exhibited antifungal and antimicrobial activity against Gram-positive bacteria. 
Figure 28. Structures of quinolizidine (261–263) and indolizidine (264–266) alkaloids. 
 
Tasmanian collections of C. cylindrica yielded the tricyclic alkaloids cylindricines A–K  
(267–277) [175-177]; cylindricine B (268) represented the first example of the new 
perhydropyrido[2,1-j]quinoline ring system, while cylindricine A (269) is the first perhydropyrrolo-
[2,1-j]quinoline known from nature (Figure 29). The skeleton of cylindricines A (267), C–I (269–275), 
and K (277) is closely related to the indolizidine system of piclavines by having an extra 6-membered 
carbocyclic fused ring. In the same way, structures of cylindricines B (268) and J (276) are related to 
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the quinolizidine system of the clavepictines and pictamines. Cylindricines F (272) and G (273) are the 
first thiocyanates from an ascidian. Closely related to cylindricines A and B, are polycitorols A (278) 
and B (279), isolated from a marine ascidian of the family Polycitoridae [178]; they lack C-4 
oxygenation found in cylindricines and have a OH group instead of a chlorine atom at  
C-13 and a butyl instead of a hexyl appendage at C-2 (Figure 29). Other analogous metabolites are 
lepadiformines A–C (280–282) isolated from C. lepadiformis and C. moluccensis [179,180] and 
fasicularin (283) from Nephteis fasicularis [181]. The initially reported structure of lepadiformine A 
was revised through its total synthesis; in the same study fasicularin (283) was also synthesized, 
allowing its absolute configuration to be assigned (Figure 29) [182]. Early biological experiments on 
fasicularin suggested that its cytotoxic properties may stem from its ability to damage cellular DNA [181]. 
Successive studies revealed fasicularin as the first natural product found to generate a DNA-alkylating 
aziridinium ion via a mechanism analogous to the clinically used anticancer drugs mechlorethamine, 
melphalan, and chlorambucil [183]. Biological studies on lepadiformines showed that they have 
marked effects on the cardiovascular system when tested on frog atrial myocytes, the potency varying 
with the alkaloid structure [180]. 
Figure 29. Structures of tricyclic lysine-derived alkaloids from ascidians. 
 
 
 
 
 
 
 
 
 
 
 
 
7. Protoalkaloids 
Ascidians have been also the source of protoalkaloids, simple amines in which the nitrogen is not in 
a heterocyclic ring. Clavelina and Pseudodistoma genera have been prolific in the production of linear 
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2-aminoalkanols and their unsaturated and/or acetylated derivatives. Structurally, these compounds are 
related to the sphingosine derivatives, which are central structural elements of sphingolipids and 
important constituents of the lipid portion of cell membranes in living organisms. The carbon chain 
length of these sphingolipid derivatives vary from C12 to C18 amino alcohols. Examples are the C12 
saturated amino alcohol (2S,3R)-2-aminododecanol-3-ol (284) isolated from C. oblonga [184], the 
clavaminols A–N (285–296), twelve saturated and unsaturated cytotoxic sphingoids isolated from the 
Mediterranean C. phlegraea [185,186], and the antifungal 2-amino alcohol 297 isolated from an 
Australian Didemnum sp. (Figure 30) [187]. Crucigasterins 277, 275 and 225 (298–300) and A–E, and 
obscuraminols A–F (301–306) are examples of polyunsaturated 2-amino-3-alkanols; they have been isolated 
as their diacetyl derivative from P. crugigaster and P. obscurum, respectively (Figure 30) [188,189]. 
Figure 30. Structures of linear 2-aminoalkanols. 
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establish its absolute stereochemistry [191]. Other sphingosine-related compounds are aplidiasphingosine 
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(Figure 31) [192,193]. 
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Figure 31. Structures of amaminols (307, 308), aplidiasphingosine (309), and lipids 310 and 311. 
Didemniserinolipids A–C (312–314), from a tunicate of the family Didemnidae [194], are 
unprecedented antibacterial serinolipids, compounds containing a unique serinol component and a  
6,8-dioxabicyclo[3.2.1]octane core. After its first disclosure, structure of (+)-didemniserinolipid B 
(313) was revised, as that shown, through its synthesis, which allowed also to assign to the compound 
the 8R,9R,10R,13S,31S absolute stereochemistry (Figure 32) [195]. Further serinolipid derivatives, 
shishididemniols A–E (315–319) have been isolated as antibacterial constituents of a tunicate of the 
family Didemnidae [196,197]; they are complex lipids with tyramine-derived tether and two serinol 
units (Figure 32). An unidentified tunicate from Pohnpei Micronesia yielded sagittamides A (320) and 
B (321), C26 dicarboxylic acids that acylate terminal L-valine and L-ornithine groups [198] and contain 
an unprecedented internal O-hexacetyl-1,2,3,4,5,6-hexaol moiety (Figure 32). The stereochemistry of 
sagittamide A has been extensively investigated; its absolute configuration has been established 
through a detailed 1H NMR analysis of the two remote diastereomers, followed by doping experiments 
of them with the authentic natural product [199]. 
Figure 32. Structures of didemniserinolipids (312–314), shishididemniols (315–319), and 
sagittamides (320–321). 
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8. Dimeric Steroidal Alkaloids 
The ritterazines (A–Z, 322–347), isolated from Ritterella tokioka, form a family of dimeric steroidal 
alkaloids [200-204]. They are closely related in structure to cephalostatins, isolated from the marine 
worm Cephalodiscus gilchristi [205]; cephalostatin 1 has been proved to be one of the most powerful 
cancer cell growth inhibitors with an ED50 value of 0.1–0.001 pM. 
The ritterazines and cephalostatines share many common structural features. Both consist of two 
highly oxygenated C27 steroid units fused via a pyrazine ring at C-2 and C-3; both chains of the 
steroid units usually form either 5/5 or 5/6 spiroketals. While cephalostatins in general are more 
oxygenated on the right side, the ritterazines have the more oxygenated left side. Hydroxyl groups are 
seen at C-12, C-17, C-23, C-26, C-12′, and C-23′ in the cephalostatins, whereas C-12, C-7′, C-12′,  
C-17′, and C-25′ are hydroxylated in the ritterazines (Figure 33) [206]. 
Figure 33. Structures of ritterazines A–Z (323–347). 
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Although less potent than cephalostatins, ritterazines also possess high inhibitory activity against a 
series of human cancer cell lines. Not surprisingly, the most active constituent of R. tokioka (ritterazine 
B, 323) contains nearly the same right-hand side steroidal unit (323: no 17R-hydroxy moiety) as the 
most active cephalostatins. A COMPARE pattern-recognition analysis gave correlation coefficients of 
~0.9 between cephalostatins and ritterazines in NCI-10 cell lines, suggesting they share the same 
mechanism. However, the antineoplastic mechanism of the cephalostatins is presently largely 
unknown. The fingerprint of cephalostatin activity in the NCI 60-tumor panel is quite different from 
other known anticancer agents, likely indicating a new mechanism of action. Recent studies revealed 
that cephalostatin 1 affects cells by disrupting the mitochondrial transmembrane potential and, thus, 
inducing apoptosis [207]. Pro-apoptotic properties have also been demonstrated for ritterazine B (323) 
although apoptosis induced by this compound appeared to be independent of the caspase pathway. 
Neither cleavage nor degradation of caspase targets was indeed observed, indicating that ritterazine B 
might be a potent inducer of apoptosis acting via a novel antimitotic mechanism [208]. The relative 
simplicity of ritterazines promises greater synthetic accessibility with probable retention of significant 
bioactivity. Isolation of closely related cephalostatins and ritterazines from different phyla raises 
questions as to the true origin of bissteroidal pyrazines; a shared symbiontic microorganism could be 
responsible for the biosynthesis of these compounds [207]. 
9. Conclusions 
An intensive research effort during the last 25 years has generated an impressive number of 
alkaloids isolated from marine ascidians, which remain unique among marine invertebrates in that they 
overwhelmingly produce this kind of metabolites. Many of these compounds exhibited biomedically 
important activities; among them, cytotoxicity is the most frequently listed activity. Unfortunately, the 
chemical ecology of these organisms has not received significant attention and several intriguing 
aspects of their chemistry still remain unsettled. These include whether symbionts, which are 
commonly associated with ascidians, play a role in their secondary metabolism, and what purpose 
these compounds serve for the producing organism in nature. 
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